{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:55:35Z","timestamp":1778820935804,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST106-2320-B-016-001"],"award-info":[{"award-number":["MOST106-2320-B-016-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Defense Medical Center","award":["MAB-106-078"],"award-info":[{"award-number":["MAB-106-078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11095-018-2550-y","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T11:06:23Z","timestamp":1546427183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fundamentals of Pharmacokinetics to Assess the Correlation Between Plasma Drug Concentrations and Different Blood Sampling Methods"],"prefix":"10.1007","volume":"36","author":[{"given":"Wei-Ching","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Lun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ning","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-896X","authenticated-orcid":false,"given":"Hong-Jaan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"issue":"2","key":"2550_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-5173(00)00344-6","volume":"201","author":"R Panchagnula","year":"2000","unstructured":"Panchagnula R, Thomas NS. Biopharmaceutics and pharmacokinetics in drug research. Int J Pharm. 2000;201(2):131\u201350.","journal-title":"Int J Pharm"},{"issue":"5","key":"2550_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/med.1015","volume":"21","author":"GR Jang","year":"2001","unstructured":"Jang GR, Harris RZ, Lau DT. Pharmacokinetics and its role in small molecule drug discovery research. Med Res Rev. 2001;21(5):382\u201396.","journal-title":"Med Res Rev"},{"issue":"7493","key":"2550_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/507423a","volume":"507","author":"S Perrin","year":"2014","unstructured":"Perrin S. Preclinical research: make mouse studies work. Nature. 2014;507(7493):423\u20135.","journal-title":"Nature"},{"issue":"2","key":"2550_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.vascn.2007.05.006","volume":"56","author":"YH Hui","year":"2007","unstructured":"Hui YH, Huang NH, Ebbert L, Bina H, Chiang A, Maples C, et al. Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs. J Pharmacol Toxicol Methods. 2007;56(2):256\u201364.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"9","key":"2550_CR5","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1023\/A:1025722614154","volume":"20","author":"L Illum","year":"2003","unstructured":"Illum L, Hinchcliffe M, Davis SS. The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model. Pharm Res. 2003;20(9):1474\u201384.","journal-title":"Pharm Res"},{"issue":"8","key":"2550_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2165\/00003088-200645080-00006","volume":"45","author":"M Darwish","year":"2006","unstructured":"Darwish M, Kirby M, Robertson P Jr, Hellriegel E, Jiang JG. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clin Pharmacokinet. 2006;45(8):843\u201350.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"2550_CR7","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/jps.2600711211","volume":"71","author":"WM Johannessen","year":"1982","unstructured":"Johannessen WM, Tyssebotn IM, Aarbakke J. Antipyrine and acetaminophen kinetics in the rat: comparison of data based on blood samples from the cut tail and acannulated femoral artery. J Pharm Sci. 1982;71(12):1352\u20136.","journal-title":"J Pharm Sci"},{"issue":"2","key":"2550_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1(2):87\u201393.","journal-title":"J Pharmacol Pharmacother"},{"issue":"3","key":"2550_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00003088-198917030-00004","volume":"17","author":"WL Chiou","year":"1989","unstructured":"Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part I). Clin Pharmacokinet. 1989;17(3):175\u201399.","journal-title":"Clin Pharmacokinet"},{"key":"2550_CR10","doi-asserted-by":"crossref","unstructured":"de Pont AC, Hofstra JJ, Pik DR, Meijers JC, Schultz MJ. Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study. Crit Care. 2007;11(5):R102.","DOI":"10.1186\/cc6119"},{"issue":"1","key":"2550_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","volume":"22","author":"CY Wu","year":"2005","unstructured":"Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport\/absorption\/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005;22(1):11\u201323.","journal-title":"Pharm Res"},{"issue":"4","key":"2550_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","volume":"13","author":"LZ Benet","year":"2011","unstructured":"Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J. 2011;13(4):519\u201347.","journal-title":"AAPS J"},{"issue":"1","key":"2550_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1208\/s12248-015-9845-2","volume":"18","author":"CM Hosey","year":"2016","unstructured":"Hosey CM, Chan R, Benet LZ. BDDCS predictions, self-correcting aspects of BDDCS assignments, BDDCS assignment corrections, and classification for more than 175 additional drugs. AAPS J. 2016;18(1):251\u201360.","journal-title":"AAPS J"},{"issue":"1","key":"2550_CR14","first-page":"49","volume":"33","author":"M Ahmad","year":"2011","unstructured":"Ahmad M, Qamar-uz-Zaman M, Madni MA, Minhas M, Atif M, Naveed A, et al. Pharmacokinetic and bioavailability studies of commercially available simvastatin tablets in healthy and moderately hyperlipidemic human subjects. J Chem Soc Pak. 2011;33(1):49\u201354.","journal-title":"J Chem Soc Pak"},{"key":"2550_CR15","doi-asserted-by":"crossref","unstructured":"Gertz M, Harrison A, Houston JB, Galetin A. Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. Drug Metab Dispos. 2010;38(7):1147\u201358.","DOI":"10.1124\/dmd.110.032649"},{"issue":"2","key":"2550_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1023\/A:1007525616017","volume":"17","author":"X Wu","year":"2000","unstructured":"Wu X, Whitfield LR, Stewart BH. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res. 2000;17(2):209\u201315.","journal-title":"Pharm Res"},{"key":"2550_CR17","doi-asserted-by":"crossref","unstructured":"Lee JB, Zgair A, Taha DA, Zang X, Kagan L, Kim TH, et al. Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays. Eur J Pharm Biopharm. 2017;114:38\u201342.","DOI":"10.1016\/j.ejpb.2016.12.027"},{"key":"2550_CR18","doi-asserted-by":"crossref","unstructured":"Li J, Wang Y, Zhang W, Huang Y, Hein K, Hidalgo IJ. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems. Drug Metab Dispos. 2012;40(11):2102\u20138.","DOI":"10.1124\/dmd.112.045666"},{"issue":"2","key":"2550_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/B:PHAM.0000016242.48642.71","volume":"21","author":"M Yazdanian","year":"2004","unstructured":"Yazdanian M, Briggs K, Jankovsky C, Hawi A. The \u201chigh solubility\u201d definition of the current FDA guidance on biopharmaceutical classification system may be too strict for acidic drugs. Pharm Res. 2004;21(2):293\u20139.","journal-title":"Pharm Res"},{"issue":"11","key":"2550_CR20","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/jps.1127","volume":"90","author":"BD Rege","year":"2001","unstructured":"Rege BD, Yu LX, Hussain AS, Polli JE. Effect of common excipients on Caco-2 transport of low-permeability drugs. J Pharm Sci. 2001;90(11):1776\u201386.","journal-title":"J Pharm Sci"},{"issue":"4","key":"2550_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11306-013-0605-y","volume":"10","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, Hsiong CH, Pao LH, Chang WL, Zhang LJ, Lin MJ, et al. New finding of nalbuphine metabolites in men: NMR spectroscopy and UPLCMS\/MS spectrometry assays in a pilot human study. Metabolomics. 2014;10(4):709\u201318.","journal-title":"Metabolomics"},{"key":"2550_CR22","unstructured":"U.S. Food and Drug Administration. Bioanalytical method validation guidance for industry. 2018 May 21. Available from: \n                    https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.pdf\n                    \n                  ."},{"key":"2550_CR23","unstructured":"European medicines agency. Guideline on bioanalytical method validation. 2011 July 21. Available from: \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf\n                    \n                  ."},{"issue":"1","key":"2550_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jchromb.2007.09.040","volume":"860","author":"X Chen","year":"2007","unstructured":"Chen X, Deng P, Dai X, Zhong D. Simultaneous determination of amodiaquine and its active metabolite in human blood by ion-pair liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2007;860(1):18\u201325.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"13","key":"2550_CR25","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS. Anal Chem. 2003;75(13):3019\u201330.","journal-title":"Anal Chem"},{"issue":"1 Pt 2","key":"2550_CR26","first-page":"H3","volume":"276","author":"M Samaja","year":"1999","unstructured":"Samaja M, Allibardi S, Milano G, Neri G, Grassi B, Gladden LB, et al. Differential depression of myocardial function and metabolism by lactate and H+. Am J Phys. 1999;276(1 Pt 2):H3\u20138.","journal-title":"Am J Phys"},{"issue":"6","key":"2550_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1007\/s11095-014-1581-2","volume":"32","author":"N Tsamandouras","year":"2015","unstructured":"Tsamandouras N, Dickinson G, Guo Y, Hall S, Rostami-Hodjegan A, Galetin A, et al. Development and application of a mechanistic pharmacokinetic model for simvastatin and its active metabolite simvastatin acid using an integrated population PBPK approach. Pharm Res. 2015;32(6):1864\u201383.","journal-title":"Pharm Res"},{"issue":"1-3","key":"2550_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2550_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/156802611794480918","volume":"11","author":"X Liu","year":"2011","unstructured":"Liu X, Chen C, Hop CE. Do we need to optimize plasma protein and tissue binding in drug discovery? Curr Top Med Chem. 2011;11(4):450\u201366.","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"2550_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1517\/17425255.2011.586336","volume":"7","author":"M Pellegatti","year":"2011","unstructured":"Pellegatti M, Pagliarusco S, Solazzo L, Colato D. Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug? Expert Opin Drug Metab Toxicol. 2011;7(8):1009\u201320.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2550_CR31","volume-title":"Applied biopharmaceutics & pharmacokinetics","author":"L Shargel","year":"2015","unstructured":"Shargel L, Andrew B, Wu-Pong S. Applied biopharmaceutics & pharmacokinetics. New York: McGraw-Hill Medical Publishing Division; 2015."},{"key":"2550_CR32","volume-title":"Pharmacokinetics (Drugs and the Pharmaceutical Sciences)","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D. Pharmacokinetics (Drugs and the Pharmaceutical Sciences). New York: CRC Press; 1982."},{"key":"2550_CR33","volume-title":"Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists","author":"Y Kwon","year":"2001","unstructured":"Kwon Y. Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists. New York: Springer; 2001."},{"issue":"15","key":"2550_CR34","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","volume":"58","author":"DA Smith","year":"2015","unstructured":"Smith DA, Beaumont K, Maurer TS, Di L. Volume of distribution in drug design. J Med Chem. 2015;58(15):5691\u20138.","journal-title":"J Med Chem"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2550-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T19:35:43Z","timestamp":1577907343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2550-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2550-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}